Boston Trust Walden Corp Grows Position in Edwards Lifesciences Co. (NYSE:EW)
Boston Trust Walden Corp grew its position in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 88.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 282,372 shares of the medical research company’s s
Source link